Position in CV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$55,310
-$419,676 QoQ
Shares Held
7,297
-88.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 49 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. CV ranks #102 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
16,352,420 | $697,921,281 | |
| 2 | ABT |
Abbott Laboratories
|
7,356,093 | $667,491,874 | |
| 3 | SYK |
Stryker Corp
|
1,909,680 | $601,243,647 | |
| 4 | MDT |
Medtronic plc
|
5,551,443 | $434,289,383 | |
| 5 | DXCM |
Dexcom Inc
|
6,065,779 | $408,530,211 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
2,758,615 | $237,489,163 | |
| 7 | PEN |
Penumbra Inc
|
703,822 | $222,231,795 | |
| 8 | EW |
Edwards Lifesciences Corp
|
2,350,656 | $212,640,338 |
All Filings in CV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,310 | 7,297 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $474,986 | 65,156 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $59,724 | 5,587 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,519 | 1,967 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||